More than 1 in 10 U.S. adults is currently taking a GLP-1 weight-loss drug. And these medicines are getting cheaper seemingly ...

Amgen's fair value estimate has been nudged from US$349.66 to US$352.23 per share, a small move that still matters if you are ...

Rosie O’Donnell has said her physical transformation is “completely shocking” ...

In high-risk patients without prior heart attack or stroke who underwent percutaneous coronary intervention, evolocumab ...

Amgen stock could offer attractive long-term upside for investors willing to ride through near-term volatility.

As 2026 brings the first wave of Medicare drug price negotiations under the Inflation Reduction Act, the landscape for high-cost cardiovascular medications like Repatha (evolocumab) has shifted ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Amgen delivers consistent, market-beating returns, supported by a robust growth portfolio and prudent capital allocation.

Amgen Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation with TipRanks’ tru ...

Prospective clinical trials needed to validate the findings ...

President Donald Trump’s drug-pricing platform TrumpRx is expanding to offer 600 generic medications — and partner with billionaire “Shark Tank” investor Mark Cuban. The growth of the federally run ...

One of the most common questions I hear from patients is, "My cholesterol was flagged as abnormal, but you told me everything looked good. How can that be?" Recently, a patient named Rose asked ...